RCM
RNC Capital Management Portfolio holdings
AUM
$2.06B
This Quarter Return
-21.02%
1 Year Return
+23.91%
3 Year Return
+56.62%
5 Year Return
+116.12%
10 Year Return
+214.42%
AUM
$1.17B
AUM Growth
+$1.17B
(-26%)
Cap. Flow
-$16.6M
Cap. Flow
% of AUM
-1.42%
Top 10 Holdings %
Top 10 Hldgs %
33.62%
Holding
164
New
8
Increased
58
Reduced
56
Closed
25
Top Buys
| 1 |
Travelers Companies
TRV
|
$24.8M |
| 2 |
Gilead Sciences
GILD
|
$22.3M |
| 3 |
Tyson Foods
TSN
|
$19.6M |
| 4 |
McDonald's
MCD
|
$18.4M |
| 5 |
DuPont de Nemours
DD
|
$15.9M |
Top Sells
| 1 |
TotalEnergies
TTE
|
$29.1M |
| 2 |
MetLife
MET
|
$20.4M |
| 3 |
Wells Fargo
WFC
|
$20.1M |
| 4 |
Microsoft
MSFT
|
$16.9M |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
$16.7M |
Sector Composition
| 1 | Healthcare | 22.72% |
| 2 | Financials | 16.78% |
| 3 | Technology | 14.87% |
| 4 | Communication Services | 10.11% |
| 5 | Consumer Staples | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$372B
| $43.6M | 3.72% |
571,677
-100,790
| -15% | -$7.68M |
|
2
Bristol-Myers Squibb
BMY
$96B
| $43.5M | 3.71% |
780,466
-12,117
| -2% | -$675K |
|
3
CVS Health
CVS
$92.8B
| $42.7M | 3.64% |
719,958
-58,724
| -8% | -$3.48M |
|
4
JPMorgan Chase
JPM
$829B
| $41.3M | 3.52% |
458,667
+1,387
| +0.3% | +$125K |
|
5
Broadcom
AVGO
$1.4T
| $38.6M | 3.3% |
162,980
+31,813
| +24% | +$7.54M |
|
6
Verizon
VZ
$186B
| $38.5M | 3.28% |
716,518
-2,992
| -0.4% | -$161K |
|
7
United Parcel Service
UPS
$74.1B
| $38.4M | 3.28% |
411,185
+139,370
| +51% | +$13M |
|
8
Amgen
AMGN
$155B
| $36.3M | 3.1% |
179,265
-482
| -0.3% | -$97.7K |
|
9
Cisco
CSCO
$274B
| $35.8M | 3.06% |
911,067
-98,115
| -10% | -$3.86M |
|
10
TSMC
TSM
$1.2T
| $35.3M | 3.01% |
739,354
-248,995
| -25% | -$11.9M |
|
11
Blackrock
BLK
$175B
| $34.3M | 2.93% |
77,946
+25,867
| +50% | +$11.4M |
|
12
Home Depot
HD
$405B
| $32.3M | 2.76% |
173,043
+38,281
| +28% | +$7.15M |
|
13
Chevron
CVX
$324B
| $31.2M | 2.66% |
430,134
+58,713
| +16% | +$4.25M |
|
14
Eli Lilly
LLY
$657B
| $30.8M | 2.62% |
221,712
-5,163
| -2% | -$716K |
|
15
AT&T
T
$209B
| $30.4M | 2.59% |
1,042,991
-392,901
| -27% | -$11.5M |
|
16
Omnicom Group
OMC
$15.2B
| $30.3M | 2.58% |
551,152
+125,697
| +30% | +$6.9M |
|
17
Citigroup
C
$178B
| $30.1M | 2.56% |
713,735
-6,244
| -0.9% | -$263K |
|
18
Johnson & Johnson
JNJ
$427B
| $29.6M | 2.52% |
225,519
-2,660
| -1% | -$349K |
|
|
19
Travelers Companies
TRV
$61.1B
| $28.1M | 2.4% |
282,886
+249,308
| +742% | +$24.8M |
|
20
Altria Group
MO
$113B
| $27.9M | 2.38% |
722,640
+30,645
| +4% | +$1.19M |
|
21
Lockheed Martin
LMT
$106B
| $26M | 2.22% |
76,850
-47,882
| -38% | -$16.2M |
|
22
Philip Morris
PM
$260B
| $25M | 2.13% |
342,772
-820
| -0.2% | -$59.8K |
|
23
Morgan Stanley
MS
$240B
| $24.7M | 2.11% |
726,636
+168,711
| +30% | +$5.74M |
|
|
24
Gilead Sciences
GILD
$140B
| $24M | 2.05% |
321,431
+298,169
| +1,282% | +$22.3M |
|
|
25
Tyson Foods
TSN
$20.2B
| $22.5M | 1.92% |
388,342
+338,813
| +684% | +$19.6M |
|